CLINICAL TRIALS PROFILE FOR RENVELA
✉ Email this page to a colleague
All Clinical Trials for Renvela
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT00785629 ↗ | A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD | Completed | DaVita Dialysis | N/A | 2009-02-01 | The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease. |
| NCT00785629 ↗ | A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD | Completed | Fresenius Medical Care North America | N/A | 2009-02-01 | The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease. |
| NCT00785629 ↗ | A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD | Completed | Genzyme, a Sanofi Company | N/A | 2009-02-01 | The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease. |
| NCT00785629 ↗ | A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD | Completed | Novartis Pharmaceuticals | N/A | 2009-02-01 | The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease. |
| NCT00785629 ↗ | A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD | Completed | Shire | N/A | 2009-02-01 | The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease. |
| NCT00785629 ↗ | A Double Blind Randomized Placebo Trial of Maintenance of Normal Serum Phosphorus in CKD | Completed | Denver Nephrologists, P.C. | N/A | 2009-02-01 | The purpose of this study is to determine the ability of 3 commercially available phosphorus binders (calcium acetate, sevelamer carbonate, and lanthanum carbonate) to achieve and maintain a phosphorus level in the normal range in patients with chronic kidney disease. |
| NCT00853242 ↗ | Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on Hemodialysis | Completed | Genzyme, a Sanofi Company | Phase 2 | 2009-02-01 | The purpose of this clinical study is to compare the effects of Genz-644470 with the effects of placebo and sevelamer carbonate (Renvela®) on the reduction of serum phosphorus in hyperphosphatemic chronic kidney disease participants on hemodialysis. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for Renvela
Condition Name
Clinical Trial Locations for Renvela
Trials by Country
Clinical Trial Progress for Renvela
Clinical Trial Phase
Clinical Trial Sponsors for Renvela
Sponsor Name
